fashion -WSS

fashion

author：fashion 2025-09-27 23:01:15 - browse：84

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： The high personal cost of affirmative action for Black doctors

focus

WSS

The high personal cost of affirmative action for Black doctors

A new deal aims to ramp up use of AI in rehab care decisions

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

5 important ways Henrietta Lacks changed medical science

Why Marc Tessier

leisure time

fashion

leisure time

Medicare details structure of new drug price negotiation program

Trump indictment: Who are the 'co

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What the US credit downgrade means for the economy, your finances

Anesthesiologist group: stop taking Ozempic before surgery

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

The cancer drug shortage isn’t new — and neither are the solutions

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Drug repurposing or repositioning? The language matters

A new deal aims to ramp up use of AI in rehab care decisions

knowledge

Pfizer's RSV vaccine recommended for approval in Europe

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Trump indictment: Who are the 'co

Infectious disease expert Jeanne Marrazzo assumes Fauci role

The high personal cost of affirmative action for Black doctors

Sage hopes for a blockbuster in antidepressant now before FDA

explore

leisure time

focus

focus